Government-Owned Inventions; Availability for Licensing, 49388 [2017-23178]
Download as PDF
<![CDATA[
49388
Federal Register / Vol. 82, No. 205 / Wednesday, October 25, 2017 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Career Development in
Environmental Research.
Date: November 2, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health
Keystone Building, 530 Davis Drive, Research
Triangle Park, NC 27709 (Virtual Meeting).
Contact Person: Laura A. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, 919–541–2824, laura.thomas@
nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: October 20, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–23180 Filed 10–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health.
Notice.
AGENCY:
sradovich on DSK3GMQ082PROD with NOTICES
[FR Doc. 2017–23178 Filed 10–24–17; 8:45 am]
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by emailing the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive
SUMMARY:
VerDate Sep<11>2014
22:06 Oct 24, 2017
Jkt 244001
Segmented Metallic Guidewires
Description of Technology: The
invention pertains to segmented
metallic guidewires that are suitable for
MRI catheterization. Guidewires contain
plurality of short conductive metallic
segments that are individually short
enough to not resonate during MR
imaging. The conductive segments are
electrically insulated from each other
and mechanically coupled together endto-end via connectors, such as stiffness
matched connectors, to provide a
sufficiently long, strong, and flexible
guidewire for catheterization that is
non-resonant during MRI.
Potential Commercial Applications:
Endovascular interventions.
Inventors: Robert Lederman, Ozgur
Kocaturk, Burcu Basar (NHLBI).
Intellectual Property: HHS Reference
No. E–253–2014/0, U.S. Provisional
Patent Application 61/066,167 filed
October 20, 2014, International Patent
Application PCT/US2015/056266 filed
October 19, 2015, European Patent
Application 15787824.0 October 19,
2015 and U.S. Patent Application 15/
514,744 filed March 27, 2017.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Dated: October 18, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
Government-Owned Inventions;
Availability for Licensing
ACTION:
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
SUPPLEMENTARY INFORMATION: This
notice is in accordance with 35 U.S.C.
209 and 37 CFR part 404 to achieve
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing. A description of the
technology follows.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; R01/F31/
K01/K99 Conflicts.
Date: December 1, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine/Center
for Scientific Review, 6701 Rockledge Drive,
Room 3042, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Zoe E. Huang, MD,
Scientific Review Officer, Division of
Extramural Programs, National Library of
Medicine, NIH, 6705 Rockledge Drive, Suite
301, Bethesda, MD 20892–7968, 301–594–
4937, huangz@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: October 19, 2017.
Michelle Trout,
Program Analyst, Office of the Federal
Advisory Committee Policy.
[FR Doc. 2017–23129 Filed 10–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Multi-
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 82, Number 205 (Wednesday, October 25, 2017)]
[Notices]
[Page 49388]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S.
FOR FURTHER INFORMATION CONTACT: Licensing information and copies of
the patent applications listed below may be obtained by emailing the
indicated licensing contact at the National Heart, Lung, and Blood,
Office of Technology Transfer and Development Office of Technology
Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892-2479;
telephone: 301-402-5579. A signed Confidential Disclosure Agreement may
be required to receive copies of the patent applications.
SUPPLEMENTARY INFORMATION: This notice is in accordance with 35 U.S.C.
209 and 37 CFR part 404 to achieve commercialization of results of
federally-funded research and development. Foreign patent applications
are filed on selected inventions to extend market coverage for
companies and may also be available for licensing. A description of the
technology follows.
Segmented Metallic Guidewires
Description of Technology: The invention pertains to segmented
metallic guidewires that are suitable for MRI catheterization.
Guidewires contain plurality of short conductive metallic segments that
are individually short enough to not resonate during MR imaging. The
conductive segments are electrically insulated from each other and
mechanically coupled together end-to-end via connectors, such as
stiffness matched connectors, to provide a sufficiently long, strong,
and flexible guidewire for catheterization that is non-resonant during
MRI.
Potential Commercial Applications: Endovascular interventions.
Inventors: Robert Lederman, Ozgur Kocaturk, Burcu Basar (NHLBI).
Intellectual Property: HHS Reference No. E-253-2014/0, U.S.
Provisional Patent Application 61/066,167 filed October 20, 2014,
International Patent Application PCT/US2015/056266 filed October 19,
2015, European Patent Application 15787824.0 October 19, 2015 and U.S.
Patent Application 15/514,744 filed March 27, 2017.
Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019;
[email protected].
Dated: October 18, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood
Institute, Office of Technology Transfer and Development.
[FR Doc. 2017-23178 Filed 10-24-17; 8:45 am]
BILLING CODE 4140-01-P
